Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments that promise better outcomes.
What progress has been made by the pharma companies in integrating generative AI into their operations and what advances would we see five years from now?
This event will speak to industry experts to get their perspectives and predictions on how current trends will shape the future of generative AI in pharma.